Given that LTL is a non-specific biomarker associated with multiple processes in the body, such as oxidative stress, inflammation, immune function, cardiovascular function [7, 8, 55], any mechanistic proposals on the relationship between APOE ε4 carriage and LTL in AD etiology would be premature based on the present observational findings. This evidence concerns the gene APOE and Alzheimer disease.